sec filing
ZU
NASDAQ · ZURA
Zura Bio Limited
Healthcare · Biotechnology
$4.11
Down-$0.03 (-0.72%)
Updated Oct 3, 2026, 9:53 PM
SID Score
2.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 263.34M
- P/E ratio
- -5.71
- Dividend yield
- 0.00%
- 52-week range
- $3.25 – $7.44
- Volume
- 2.95M
- Avg. volume
- 1.66M
Price performance · ZURA
ZURA price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 2, 2026
ZURA closed at $4.11 after 20 trading sessions, down 34.03% for the selected period.
- Last close
- $4.11
- Period change
- -34.03%
- Period low
- $4.00
- Period high
- $6.23
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 2, 2026 | $4.21 | $4.36 | $4.075 | $4.11 | 2.95M |
| Oct 1, 2026 | $4.13 | $4.245 | $4.00 | $4.14 | 2.91M |
| Sep 30, 2026 | $4.04 | $4.23 | $3.98 | $4.16 | 3.33M |
| Sep 29, 2026 | $4.10 | $4.19 | $3.9227 | $4.00 | 2.04M |
| Sep 28, 2026 | $4.03 | $4.19 | $3.92 | $4.10 | 1.47M |
| Sep 25, 2026 | $4.27 | $4.28 | $3.915 | $4.04 | 1.51M |
| Sep 24, 2026 | $4.32 | $4.32 | $3.84 | $4.16 | 3.43M |
| Sep 23, 2026 | $4.525 | $4.55 | $4.162 | $4.33 | 2.06M |
| Sep 22, 2026 | $4.56 | $4.62 | $4.45 | $4.51 | 2.15M |
| Sep 21, 2026 | $4.55 | $4.55 | $4.37 | $4.50 | 1.11M |
| Sep 18, 2026 | $4.50 | $4.6082 | $4.40 | $4.46 | 1.66M |
| Sep 17, 2026 | $4.72 | $4.84 | $4.53 | $4.57 | 1.67M |
| Sep 16, 2026 | $4.94 | $4.98 | $4.5839 | $4.61 | 1.27M |
| Sep 15, 2026 | $5.20 | $5.24 | $4.74 | $4.93 | 2.64M |
| Sep 14, 2026 | $5.21 | $5.36 | $5.15 | $5.21 | 1.05M |
| Sep 11, 2026 | $5.48 | $5.58 | $5.15 | $5.21 | 1.42M |
| Sep 10, 2026 | $5.60 | $5.74 | $5.365 | $5.38 | 1.15M |
| Sep 9, 2026 | $6.04 | $6.0502 | $5.63 | $5.71 | 1.73M |
| Sep 8, 2026 | $6.23 | $6.23 | $5.90 | $6.13 | 1.62M |
| Sep 4, 2026 | $5.80 | $6.26 | $5.6296 | $6.23 | 1.39M |
Latest ZURA news
The latest Smart Investors Daily articles mentioning ZURA.
Stock researchCompany · Overview
Company
Market Activity
Research & News
Loading stock research…

